Joined Today: 10

AMGN Amgen, Stock Message Board

All Messages

AMGN Message Board Home | Join The AMGN Group |

#100: Amgen Announces Voting Results of Annual Meeting of Stockholders
NewsBot	May 9, 2008 06:21:24 PM
Amgen (NASDAQ:AMGN), today announced results of voting at the company’s Annual Meeting of Stockholders, held at the Four Seasons Hotel Westlake Village in Westlake Village, Calif.... view message ignore post recommend post

#99: Amgen's Oncology Pipeline Data Highlighted at Upcoming Scientific Meeting
TheMachine	April 8, 2008 02:30:13 AM
Five Investigational Compounds from Robust Ongoing Clinical Trials Program Target Novel Cancer Pathways Amgen (NASDAQ: AMGN) today announced that results from... view message ignore post recommend post

#97: Pivotal Phase 3 NPLATE(TM) Study in Non-Splenectomized Patients Met Primary Endpoints and Out of the Gate: Celgene Falls
FastFun	December 12, 2007 10:15:51 PM
--(www.USEquityNews.com)-- 12/11/2007 - Pharmaceutical industry alert provided by U.S. Equity News. Amgen Inc. (NASDAQ: AMGN) recently announced results from a second randomized, pivotal... view message ignore post recommend post

#96: Pivotal Phase 3 NPLATE(TM) Study in Non-Splenectomized Patients Met Primary Endpoints
FastFun	December 10, 2007 10:05:55 PM
Data Also Shows Potential of Nplate as a Long-term Treatment Option for Chronic Adult Immune Thrombocytopenia Purpura Amgen Inc. (NASDAQ:AMGN) today announced results from a second... view message ignore post recommend post

#95: Pivotal Phase 3 Romiplostim Study in Splenectomized Patients Meets Primary Endpoints
FastFun	December 10, 2007 10:05:13 PM
Data Show Romiplostim Increased and Sustained Platelet Counts in Splenectomized Adult Patients with Immune Thrombocytopenic Purpura Amgen Inc. (NASDAQ:AMGN) today announced results from... view message ignore post recommend post

#94: Amgen in Discussions with FDA to Update U.S. Prescribing Information for ESAs
FastFun	December 7, 2007 08:25:04 PM
Revised ESA Labeling to be Based on New Data from PREPARE and GOG Studies Amgen Inc. (NASDAQ:AMGN) today announced the company is in discussions with the U.S. Food and Drug... view message ignore post recommend post

#93: Vectibix(R) Approved in the European Union for the Treatment of Metastatic Colorectal Cancer
FastFun	December 7, 2007 08:24:06 PM
Clinically Relevant Biomarker Provides Physicians With the Ability to Predict the Patients Most Likely to Respond to Vectibix Treatment Amgen (NASDAQ: AMGN) today announced that the... view message ignore post recommend post

#92: Amgen Announces Interim Results of Aranesp(R) ''PREPARE'' Study in Breast Cancer Patients
FastFun	December 7, 2007 08:16:56 PM
Amgen, Inc. (NASDAQ: AMGN) today announced that it had received interim results from the independent investigator-sponsored “PREPARE” study, an open-label, randomized, multicenter Phase 3... view message ignore post recommend post

#91: Amgen Hires Former Clinton Aide to Lobby and Gilead Seeks Aztreonam Lysine Approval
FastFun	November 26, 2007 08:31:13 PM
--(www.USEquityNews.com)-- 11/19/2007 - Pharmaceutical industry alert provided by U.S. Equity News. Drug maker Amgen Inc. (NASDAQ: AMGN) hired Sally Katzen, a former deputy director at... view message ignore post recommend post

#90: Gilead Sciences CEO Exercises Options and Genzyme Rises After Icahn Buys Shares
FastFun	November 26, 2007 08:28:20 PM
--(www.USEquityNews.com)-- 11/16/2007 - Pharmaceutical industry alert provided by U.S. Equity News. The president and chief executive of biopharmaceutical company Gilead Sciences Inc.... view message ignore post recommend post

#89: AMGN News Amgen to Present at the Lehman Brothers Tenth Annual Global Healthcare Conference
NewsBot	March 19, 2007 09:43:00 AM
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ:AMGN) will participate in the Lehman Brothers Tenth Annual Global Healthcare Conference on Tuesday, March 20, 2007, at the Loews... view message ignore post recommend post

#88: AMGN News Amgen to Present at the 27th Annual Cowen & Company Health Care Conference
NewsBot	March 12, 2007 11:53:00 AM
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ:AMGN) will participate in the 27th Annual Cowen & Company Health Care Conference on Tuesday, March 13th, at the Boston... view message ignore post recommend post

#87: AMGN News Amgen Announces Update To U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
NewsBot	March 9, 2007 10:07:00 AM
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved updated safety information, including a boxed... view message ignore post recommend post

#86: AMGN News Prime Minister Tony Blair Opens Major Amgen Development Centre in London
NewsBot	March 2, 2007 03:30:00 AM
UXBRIDGE, England--(BUSINESS WIRE)--Amgen (NASDAQ:AMGN) announced today that the Prime Minister Rt Hon Tony Blair MP opened Amgen’s new European Development Centre in Uxbridge,... view message ignore post recommend post

#85: AMGN News Amgen to Participate in Oncologic Drugs Advisory Committee in May
NewsBot	February 28, 2007 01:28:00 PM
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has invited the Company to participate at an upcoming... view message ignore post recommend post

Group Home | Login if you want to post a message